UAB Insight Neurosciences Volume 1 - Page 4

N O T E W O R T H Y P R E S E N TAT I O N S The UAB Pain Symposium will be March 27, 2012, at Children’s Harbor Center, Birmingham. Speakers include Emeran Mayer, MD, director, UCLA Center for Neurovisceral Sciences & Women’s Health; Kathleen Sluka, PhD, PT, director, Neurobiology of Pain Lab, University of Iowa; Maria Fitzgerald, PhD, University College London, Wellcome London Pain Consortium; Andy Ahn, MD, PhD, University of Florida Pain and Spine Center. Contact: Meredith Robbins, PhD, 205.996.7134. For details, visit Non-Profit Org. U.S. Postage NEUROSCIENCES PAID Permit No. 1256 Birmingham, AL JNWB 412 • 500 22nd Street South 1530 3RD AVE S BIRMINGHAM AL 35294-0104 VOL. 1 NO. 3 NEUROSCIENCES INSIGHT T H E The 2011 Bevill Conference on Cognition and Cognitive Disorders, presented by the UAB Comprehensive Neuroscience Center, featured such renowned investigators as Eric J. Nestler, MD, PhD, Mt. Sinai School of Medicine; Bradford C. Dickerson, MD, Harvard University; Lennart Mucke, MD, University of California, San Francisco; Li-Huei Tsai, PhD, Massachusetts Institute of Technology; and Ted Abel, PhD, University of Pennsylvania. For information on UAB CNC Events visit www. U N I V E R S I T Y O F A L A B A M A AT B I R M I N G H A M Published by the UAB Health System, 500 22nd Street South Birmingham, AL 35233 ©2012 by The Board of Trustees of The University of Alabama for the University of Alabama at Birmingham. Second class postage paid by UAB Bulk Mail Dept. Postmaster address changes to: UAB Insight, 500 22nd Street South Suite 410, 1530 3rd Ave South Birmingham, AL 35294 NEUROSCIENCES NeuroNEXT will provide quicker 23 UAB Neurologists and Neurosurgeons named Best Doctors in America® preliminary tests of FOR MORE ISS UE S OF UA B INSI G T A ND FO MO SS UES F UAB S SIGH N I S S U E H I G H L I G H T S novel treatments. NeuroNEXT to Speed Translational Research TH E LATE S T NEWS AN D UPDATE S, H TES TE N AT Barton L. Guthrie, MD Khurram Bashir, MD, MPH James M. Markert Jr, MD, MPH L. Burt Nabors III, MD Mark N. Hadley, MD NeuroNEXT to Speed UABMEDICINE.ORG/PHYSICIAN Translational Research Peter H. King, MD Winfield S. Fisher III, MD Ray L. Watts, MD Alyssa T. Reddy, MD Shin J. Oh, MD David G. Standaert, MD, PhD UAB Neurosurgeons Help Develop Ursula Isolde Wesselmann, MD David S. Geldmacher, MD John C. Wellons III, MD 1 - 80 0- 82 2- 64 78 800- 822- 6 7 0-82 2 Gwendolyn C. Claussen, MD John F. Rothrock, MD W. Jerry Oakes, MD Monisha Goyal, MD Four for UAB Leon S. Dure, MD U A B N EUR OL O G Y & NE UR OS UR GE R Y UROL OGY OLO NEUR O S U R G E U R A NKED RA NK ED B Y U. S. NE WS & W OR LD D U S NEWS WS OR REPO T RE PO RT A S ON E OF T HE N ATIO N ’S ONE O IO S O TOP HOS T TO P HO S P ITA L S . 2 Publications of Note 2 3 New Physicians 3 Cord Injuries Guidelines Brain Tumor SPORE Makes Jeffrey P. Blount, MD Erwin B. Montgomery Jr, MD TO R EF ER A PAT IENT, CA LL: O F R ATIE NT CALL : N L Acute Cervical Spine and Spinal UAB Assists in Spinal Injury Guidelines Development UAB Medicine News Michael S. Vaphiades, MD Patrick R. Pritchard, MD VIS IT UA B MEDI CINE PHY S ICIAN HQ: S A DICI N Y AN Q: Markert Leads Southern Neurology Society UAB is one of 25 inaugural members of NeuroNEXT, the federally funded neuroscience research consortium effectiveness of promising medications.” Consortium members can join trials proposed by other created in 2011 to rapidly advance new treatments for members of NeuroNEXT, thereby helping create the neurological disorders. Its first meeting of principal critical mass of subjects needed to quickly and efficiently investigators (PI) was November 18, 2011. determine if a new therapy is working. Even nonmembers “The Network for Excellence in Neuroscience Clinical of the network—academic investigators, advocacy groups Trials provides a robust, standardized, and a ccessible Clinical Trials 3 Measures of Success 3 Noteworthy Presentations 4 or foundations, small businesses, and pharmaceutical infrastructure to facilitate translational research,” says enterprises—may apply to conduct a study within the neurologist Burt Nabors, MD, principal investigator for network, which is sponsored by the National Institute of UAB. “The network should speed the process and make Neurological Disorders and Stroke. it easier to launch clinical trials and more quickly gauge Nabors says that UAB’s long-standing track record for continued on page 2